University Of Maryland, Baltimore
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
Indocyanine Green Tissue Perfusion Monitoring
Completed
- Conditions
- Regional Blood FlowWound Heal
- Interventions
- Device: fluorescence-mediated photoplethysmography
- First Posted Date
- 2016-12-01
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 15
- Registration Number
- NCT02978560
- Locations
- ๐บ๐ธ
Baltimore Medical & Surgical Associates PA, Towson, Maryland, United States
Minocycline and Tobacco Craving in Smokers With Schizophrenia
- First Posted Date
- 2016-11-18
- Last Posted Date
- 2022-01-06
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 32
- Registration Number
- NCT02968602
- Locations
- ๐บ๐ธ
Maryland Psyciatric Research Center, Catonsville, Maryland, United States
Harnessing Placebo Effects in Methadone Treatment
Not Applicable
Completed
- Conditions
- Opioid-use DisorderOpioid-Related Disorders
- Interventions
- Behavioral: Open-Label Placebo (OLP)
- First Posted Date
- 2016-10-21
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 133
- Registration Number
- NCT02941809
- Locations
- ๐บ๐ธ
Maryland Methadone Treatment Center, Baltimore, Maryland, United States
Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis
Not Applicable
Completed
- Conditions
- Diabetic Ketoacidosis
- Interventions
- Other: Early administration of subcutaneous insulin glargine doseOther: IV insulin infusionDrug: IV fluid repletion
- First Posted Date
- 2016-10-11
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 18
- Registration Number
- NCT02930044
- Locations
- ๐บ๐ธ
University of Maryland Medical Center, Baltimore, Maryland, United States
Schizophrenia and the Gut Microbiome
Completed
- Conditions
- Schizoaffective DisorderSchizophrenia
- First Posted Date
- 2016-10-03
- Last Posted Date
- 2019-08-19
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 11
- Registration Number
- NCT02921243
- Locations
- ๐บ๐ธ
Maryland Psychiatric Research Center, Catonsville, Maryland, United States
Assessing the Accuracy and the Impact of Standard-practice Ventricular Drainage on Intracranial Pressure Measurements Following Traumatic Brain Injury
Withdrawn
- Conditions
- Traumatic Brain Injury
- Interventions
- Device: EVD/IVC and the IPM/Camino
- First Posted Date
- 2016-09-22
- Last Posted Date
- 2022-01-18
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT02911675
Using Spices and Herbs to Increase Vegetable Intake Among Urban High School Students
Not Applicable
Completed
- Conditions
- Poor Nutrition
- Interventions
- Other: Adding spices and herbs to school lunch vegetables
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2021-09-14
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 29
- Registration Number
- NCT02908854
- Locations
- ๐บ๐ธ
Center for Integrative Medicine University of Maryland, Baltimore, Maryland, United States
Gingival Augmentation Around Implants During Maintenance
Not Applicable
Completed
- Conditions
- Failure of Dental Implant Due to Lack of Attached Gingiva
- Interventions
- Procedure: Free gingival graftProcedure: Oral prophylaxis
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 30
- Registration Number
- NCT02904551
- Locations
- ๐บ๐ธ
Advanced General Dentistry at UMB DS, Baltimore, Maryland, United States
Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Device: Continuous glucose Monitoring (CGM) device and Point of Care (POC) blood glucoseOther: Point of Care (POC) blood glucose
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2021-06-22
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 16
- Registration Number
- NCT02904512
- Locations
- ๐บ๐ธ
Baltimore VA Medical Center, Baltimore, Maryland, United States
HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant
Phase 4
Completed
- Conditions
- Hepatitis CRenal Insufficiency, ChronicDisorder of Transplanted Kidney
- Interventions
- Drug: Post-transplant Grazoprevir and Elbasvir
- First Posted Date
- 2016-09-15
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 21
- Registration Number
- NCT02902120
- Locations
- ๐บ๐ธ
University of Maryland Medical Center, Baltimore, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath